• Je něco špatně v tomto záznamu ?

Patterns of proton therapy use in pediatric cancer management in 2016: An international survey

N. Journy, DJ. Indelicato, DR. Withrow, T. Akimoto, C. Alapetite, M. Araya, A. Chang, JH. Chang, B. Chon, ME. Confer, Y. Demizu, R. Dendale, J. Doyen, R. Ermoian, K. Gurtner, C. Hill-Kayser, H. Iwata, JY. Kim, Y. Kwok, NN. Laack, C. Lee, DH. Lim,...

. 2019 ; 132 (-) : 155-161. [pub] 20181107

Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie, Research Support, N.I.H., Intramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006732

PURPOSE: To facilitate the initiation of observational studies on late effects of proton therapy in pediatric patients, we report on current patterns of proton therapy use worldwide in patients aged less than 22 years. MATERIALS & METHODS: Fifty-four proton centers treating pediatric patients in 2016 in 11 countries were invited to respond to a survey about the number of patients treated during that year by age group, intent of treatment, delivery technique and tumor types. RESULTS: Among the 40 participating centers (participation rate: 74%), a total of 1,860 patients were treated in 2016 (North America: 1205, Europe: 432, Asia: 223). The numbers of patients per center ranged from 1 to 206 (median: 29). Twenty-four percent of the patients were <5 years of age, and 50% <10 years. More than 30 pediatric tumor types were identified, mainly treated with curative intent: 48% were CNS, 25% extra-cranial sarcomas, 7% neuroblastoma, and 5% hematopoietic tumors. About half of the patients were treated with pencil beam scanning. Treatment patterns were broadly similar across the three continents. CONCLUSION: To our knowledge, this survey provides the first worldwide assessment of proton therapy use for pediatric cancer management. Since previous estimates in the United States and Europe, CNS tumors remain the cancer types most commonly treated with protons in 2016. However, the proportion of extra-cranial tumors is growing worldwide. The typically low numbers of patients treated in each center indicate the need for international research collaborations to assess long-term outcomes of proton therapy in pediatric patients.

Aizawa Hospital Proton Therapy Center Nagano Japan

California Protons San Diego United States

Center for Proton Therapy Paul Scherrer Institute Switzerland

Children's Hospital of Philadelphia and University of Pennsylvania Roberts Proton Therapy Center Philadelphia United States

Danish Centre for Particle Therapy Aarhus Denmark

Departement of Radiation Oncology University of Maryland School of Medicine Baltimore United States

Department of Particle Therapy University Hospital Essen West German Proton Therapy Center Essen Essen Germany

Department of Radiation Oncology Centre Antoine Lacassagne 227 avenue de la Lanterne University of Côte d'Azur Nice France

Department of Radiation Oncology Hokkaido University Faculty of Medicine Sapporo Japan

Department of Radiation Oncology Mayo Clinic Rochester United States

Francis H Burr Proton Therapy Center Massachusetts General Hospital Boston United States

Hyogo Ion Beam Medical Center Tatsuno Japan

INSERM U1018 Centre for Research in Epidemiology and Population Health Cancer and Radiations Group Gustave Roussy Cancer Campus Villejuif France

Institut Curie Proton therapie Centre Orsay France

Loma Linda University Medical Center United States

Mayo Clinic Arizona Phoenix United States

Medipolis Proton Therapy and Research Center Kaghosima Japan

Nagoya Proton Therapy Center Nagoya city Japan

National Cancer Center Hospital East Kashiwa Japan

Northwestern Medicine Chicago Proton Center Warrenville United States

Orlando Health UF Health Cancer Center United States

ProCure Proton Therapy Center Oklahoma City United States

ProCure Proton Therapy Center United States

Proton Therapy Center Czech s r o Praha Czech Republic

Proton Therapy Center Fukui Prefectural Hospital Japan

Proton Therapy Center Trento Italy

ProtonTherapy Center National Cancer Center Goyang si South Korea

Provision Cares Proton Therapy Center Knoxville United States

Radiation Epidemiology Branch Division of Cancer Epidemiology and Genetics National Cancer Institute National Institutes of Health Bethesda United States

Rinecker Proton Therapy Center Muenchen Germany

Rutgers Cancer Institute of New Jersey New Brunswick United States

S Lee Kling Proton Therapy Center Washington University in St Louis United States

Samsung Proton Therapy Center Samsung Medical Center Sungkyunkwan University School of Medicine Seoul South Korea

SCCA Proton Therapy Seattle United States

Shizuoka Cancer Center Japan

Southern TOHOKU Proton Therapy Center Koriyama Japan

Texas Center for Proton Therapy Irving United States

The Skandion Clinic Uppsala Sweden

The University of Texas M D Anderson Cancer Center Department of Radiation Oncology Houston United States

Universitäts Protonentherapie Dresden Universitätsklinikum Carl Gustav Carus Germany

University Hospitals Proton Therapy Center Seidman Cancer Center Rainbow Babies and Children's Hospital Case Western Reserve University Cleveland United States

University of Florida Department of Radiation Oncology Jacksonville United States

Vanderbilt University Medical Center Department of Radiation Oncology Nashville United States

Willis Knighton Proton Center Shreveport United States

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006732
003      
CZ-PrNML
005      
20200527095826.0
007      
ta
008      
200511s2019 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.radonc.2018.10.022 $2 doi
035    __
$a (PubMed)30414759
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Journy, Neige $u INSERM U1018, Centre for Research in Epidemiology and Population Health, Cancer & Radiations Group, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: neige.journy@gustaveroussy.fr.
245    10
$a Patterns of proton therapy use in pediatric cancer management in 2016: An international survey / $c N. Journy, DJ. Indelicato, DR. Withrow, T. Akimoto, C. Alapetite, M. Araya, A. Chang, JH. Chang, B. Chon, ME. Confer, Y. Demizu, R. Dendale, J. Doyen, R. Ermoian, K. Gurtner, C. Hill-Kayser, H. Iwata, JY. Kim, Y. Kwok, NN. Laack, C. Lee, DH. Lim, L. Loredo, VS. Mangona, DB. Mansur, M. Murakami, S. Murayama, T. Ogino, B. Ondrová, RR. Parikh, AC. Paulino, S. Perkins, NR. Ramakrishna, R. Richter, B. Rombi, S. Shibata, S. Shimizu, B. Timmermann, T. Vern-Gross, CJ. Wang, DC. Weber, JB. Wilkinson, P. Witt Nyström, TI. Yock, RA. Kleinerman, A. Berrington de Gonzalez,
520    9_
$a PURPOSE: To facilitate the initiation of observational studies on late effects of proton therapy in pediatric patients, we report on current patterns of proton therapy use worldwide in patients aged less than 22 years. MATERIALS & METHODS: Fifty-four proton centers treating pediatric patients in 2016 in 11 countries were invited to respond to a survey about the number of patients treated during that year by age group, intent of treatment, delivery technique and tumor types. RESULTS: Among the 40 participating centers (participation rate: 74%), a total of 1,860 patients were treated in 2016 (North America: 1205, Europe: 432, Asia: 223). The numbers of patients per center ranged from 1 to 206 (median: 29). Twenty-four percent of the patients were <5 years of age, and 50% <10 years. More than 30 pediatric tumor types were identified, mainly treated with curative intent: 48% were CNS, 25% extra-cranial sarcomas, 7% neuroblastoma, and 5% hematopoietic tumors. About half of the patients were treated with pencil beam scanning. Treatment patterns were broadly similar across the three continents. CONCLUSION: To our knowledge, this survey provides the first worldwide assessment of proton therapy use for pediatric cancer management. Since previous estimates in the United States and Europe, CNS tumors remain the cancer types most commonly treated with protons in 2016. However, the proportion of extra-cranial tumors is growing worldwide. The typically low numbers of patients treated in each center indicate the need for international research collaborations to assess long-term outcomes of proton therapy in pediatric patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nádory $x epidemiologie $x radioterapie $7 D009369
650    _2
$a pediatrie $x metody $x statistika a číselné údaje $7 D010372
650    _2
$a protonová terapie $x metody $x statistika a číselné údaje $7 D061766
650    _2
$a celková dávka radioterapie $7 D011879
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Indelicato, Daniel J $u University of Florida, Department of Radiation Oncology, Jacksonville, United States.
700    1_
$a Withrow, Diana R $u Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, United States.
700    1_
$a Akimoto, Tetsuo $u National Cancer Center Hospital East, Kashiwa, Japan.
700    1_
$a Alapetite, Claire $u Institut Curie Proton therapie Centre (ICPO), Orsay, France.
700    1_
$a Araya, Masayuki $u Aizawa Hospital Proton Therapy Center, Nagano, Japan.
700    1_
$a Chang, Andrew $u California Protons, San Diego, United States.
700    1_
$a Chang, John Han-Chih $u Northwestern Medicine Chicago Proton Center, Warrenville, United States; Vanderbilt University Medical Center, Department of Radiation Oncology, Nashville, United States.
700    1_
$a Chon, Brian $u ProCure Proton Therapy Center, United States.
700    1_
$a Confer, Michael E $u ProCure Proton Therapy Center, Oklahoma City, United States.
700    1_
$a Demizu, Yusuke $u Hyogo Ion Beam Medical Center, Tatsuno, Japan.
700    1_
$a Dendale, Rémi $u Institut Curie Proton therapie Centre (ICPO), Orsay, France.
700    1_
$a Doyen, Jérôme $u Department of Radiation Oncology, Centre Antoine-Lacassagne, 227 avenue de la Lanterne, University of Côte d'Azur, Nice, France.
700    1_
$a Ermoian, Ralph $u SCCA Proton Therapy, Seattle, United States.
700    1_
$a Gurtner, Kristin $u Universitäts Protonentherapie Dresden, Universitätsklinikum Carl Gustav Carus, Germany.
700    1_
$a Hill-Kayser, Christine $u Children's Hospital of Philadelphia and University of Pennsylvania, Roberts Proton Therapy Center, Philadelphia, United States.
700    1_
$a Iwata, Hiromitsu $u Nagoya Proton Therapy Center (Nagoya City West Medical Center), Nagoya-city, Japan.
700    1_
$a Kim, Joo-Young $u ProtonTherapy Center, National Cancer Center, Goyang-si, South Korea.
700    1_
$a Kwok, Young $u Departement of Radiation Oncology, University of Maryland School of Medicine, Baltimore, United States.
700    1_
$a Laack, Nadia N $u Department of Radiation Oncology, Mayo Clinic, Rochester, United States.
700    1_
$a Lee, Choonsik $u Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, United States.
700    1_
$a Lim, Do Hoon $u Samsung Proton Therapy Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
700    1_
$a Loredo, Lilia $u Loma Linda University Medical Center, United States.
700    1_
$a Mangona, Victor S $u Texas Center for Proton Therapy, Irving, United States.
700    1_
$a Mansur, David B $u University Hospitals Proton Therapy Center, Seidman Cancer Center, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, United States.
700    1_
$a Murakami, Masao $u Southern TOHOKU Proton Therapy Center, Koriyama, Japan.
700    1_
$a Murayama, Shigeyuki $u Shizuoka Cancer Center, Japan.
700    1_
$a Ogino, Takashi $u Medipolis Proton Therapy and Research Center, Kaghosima, Japan.
700    1_
$a Ondrová, Barbora $u Proton Therapy Center Czech s.r.o, Praha, Czech Republic.
700    1_
$a Parikh, Rahul R $u Rutgers Cancer Institute of New Jersey, New Brunswick, United States.
700    1_
$a Paulino, Arnold C $u The University of Texas M.D Anderson Cancer Center, Department of Radiation Oncology, Houston, United States.
700    1_
$a Perkins, Stephanie $u S. Lee Kling Proton Therapy Center, Washington University in St. Louis, United States.
700    1_
$a Ramakrishna, Naren R $u Orlando Health UF Health Cancer Center, United States.
700    1_
$a Richter, Ronald $u Rinecker Proton Therapy Center, Muenchen, Germany.
700    1_
$a Rombi, Barbara $u Proton Therapy Center, Trento, Italy.
700    1_
$a Shibata, Satoshi $u Proton Therapy Center, Fukui Prefectural Hospital, Japan.
700    1_
$a Shimizu, Shinichi $u Department of Radiation Oncology, Hokkaido University, Faculty of Medicine, Sapporo, Japan.
700    1_
$a Timmermann, Beate $u Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Center Essen (WPE), West German Cancer Center (WTZ), German Cancer Consortium (DKTK), Essen, Germany.
700    1_
$a Vern-Gross, Tamara $u Mayo Clinic Arizona, Phoenix, United States.
700    1_
$a Wang, Chiachien J $u Willis-Knighton Proton Center, Shreveport, United States.
700    1_
$a Weber, Damien C $u Center for Proton Therapy, Paul Scherrer Institute, Switzerland.
700    1_
$a Wilkinson, John Ben $u Provision Cares Proton Therapy Center, Knoxville, United States.
700    1_
$a Witt Nyström, Petra $u The Skandion Clinic, Uppsala, Sweden; Danish Centre for Particle Therapy, Aarhus, Denmark.
700    1_
$a Yock, Torunn I $u Francis H Burr Proton Therapy Center, Massachusetts General Hospital, Boston, United States.
700    1_
$a Kleinerman, Ruth A $u Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, United States.
700    1_
$a Berrington de Gonzalez, Amy $u Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, United States.
773    0_
$w MED00004049 $t Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology $x 1879-0887 $g Roč. 132, č. - (2019), s. 155-161
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30414759 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200527095822 $b ABA008
999    __
$a ok $b bmc $g 1525590 $s 1096788
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 132 $c - $d 155-161 $e 20181107 $i 1879-0887 $m Radiotherapy and oncology $n Radiother Oncol $x MED00004049
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...